Levetiracetam as first-line monotherapy for Idiopathic Generalized Epilepsy in women.

Alejandro BallvéJavier Salas-PuigManuel QuintanaDaniel CamposArnau LlauradóMiquel RaspallElena FonsecaLaura AbrairaEstevo SantamarinaManuel Toledo

Published in: Acta neurologica Scandinavica (2021)

LEV could be an effective drug as first-line treatment for IGE in women of childbearing potential. The adverse effects are its main limitation. Comparative studies are needed in order to establish it for this indication.

Keyphrases

polycystic ovary syndrome
pregnancy outcomes
cervical cancer screening
breast cancer risk
insulin resistance
type diabetes
emergency department
pregnant women
risk assessment
clinical trial
climate change
human health
adverse drug
electronic health record
allergic rhinitis
temporal lobe epilepsy